Adcentrx gets FDA clearance for phase 1 trial of ADC for tumors

Submitted by admin on October 22, 2024 - 11:31am

Source:

Biopharma Reporter

News Tags:

Headline:

snippet:

The FDA has given clearance to Adcentrx Therapeutics' IND application for an antibody-drug conjugate (ADC) targeting solid tumors.

Search form